APA

Abreu-Velez A. M., Valencia-Yepes C. A., Upegui-Zapata Y. A., Upegui-Quiceno E., Mesa-Herrera N. R., Velazquez-Velez J. E. & Howard M. S. (20180523). Patients with a new variant of endemic pemphigus foliaceus have autoantibodies against arrector pili muscle, colocalizing with MYZAP, p0071, desmoplakins 1 and 2 and ARVCF. : Clinical and experimental dermatology.

Chicago

Abreu-Velez A M, Valencia-Yepes C A, Upegui-Zapata Y A, Upegui-Quiceno E, Mesa-Herrera N R, Velazquez-Velez J E and Howard M S. 20180523. Patients with a new variant of endemic pemphigus foliaceus have autoantibodies against arrector pili muscle, colocalizing with MYZAP, p0071, desmoplakins 1 and 2 and ARVCF. : Clinical and experimental dermatology.

Harvard

Abreu-Velez A. M., Valencia-Yepes C. A., Upegui-Zapata Y. A., Upegui-Quiceno E., Mesa-Herrera N. R., Velazquez-Velez J. E. and Howard M. S. (20180523). Patients with a new variant of endemic pemphigus foliaceus have autoantibodies against arrector pili muscle, colocalizing with MYZAP, p0071, desmoplakins 1 and 2 and ARVCF. : Clinical and experimental dermatology.

MLA

Abreu-Velez A M, Valencia-Yepes C A, Upegui-Zapata Y A, Upegui-Quiceno E, Mesa-Herrera N R, Velazquez-Velez J E and Howard M S. Patients with a new variant of endemic pemphigus foliaceus have autoantibodies against arrector pili muscle, colocalizing with MYZAP, p0071, desmoplakins 1 and 2 and ARVCF. : Clinical and experimental dermatology. 20180523.